[Breast cancer: new concepts in classification].

Rev Bras Ginecol Obstet

Departamento de Patologia, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.

Published: January 2008

AI Article Synopsis

Article Abstract

Breast cancer is the principal cause of death from cancer in women. Molecular studies of breast cancer, based in the identification of the molecular profiling techniques through cDNA microarray, had allowed defining at least five distinct sub-group: luminal A, luminal B, HER-2-overexpression, basal and 'normal' type breast-like. The technique of tissue microarrays (TMA), described for the first time in 1998, allows to study, in some samples of breast cancer, distinguished by differences in their gene expression patterns, which provide a distinctive molecular portrait for each tumor and the basis for and improved breast cancer molecular taxonomy. Another important implication is that genetic profiling may lead to the identification of new target for therapy and better predictive markers are needed to guide difficult treatment decisions. Additionally, the current pathology classification system is suboptimal, since patients with identical tumor types and stage of disease present different responses to therapy and different overall outcomes. Basal breast tumor represents one of the most intriguing subtypes and is frequently associated with poor prognosis and absence of putative therapeutic targets. Then, the purpose of this review was to resume the most recent knowledge about the breast carcinoma classification and characterization.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0100-72032008000100008DOI Listing

Publication Analysis

Top Keywords

breast cancer
16
breast
6
cancer
5
[breast cancer
4
cancer concepts
4
concepts classification]
4
classification] breast
4
cancer principal
4
principal death
4
death cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!